{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:48Z","timestamp":1793374248556,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11136-026-04393-8","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:02:00Z","timestamp":1790168520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating patient-reported outcome measurement in fibromyalgia clinical trials: a cross-sectional meta-research analysis of alignment with IMMPACT recommendations"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0485-9626","authenticated-orcid":false,"given":"Micaylon","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1751-555X","authenticated-orcid":false,"given":"Hayden","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5579-0251","authenticated-orcid":false,"given":"Lauren","family":"Kocour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8906-1345","authenticated-orcid":false,"given":"Noah","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3612-375X","authenticated-orcid":false,"given":"Makalie","family":"Lackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0428-6084","authenticated-orcid":false,"given":"Tanner","family":"Livsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6539-2569","authenticated-orcid":false,"given":"Ryan","family":"Langerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4644-0111","authenticated-orcid":false,"given":"Amy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9036-3419","authenticated-orcid":false,"given":"Arnab","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-2639","authenticated-orcid":false,"given":"Alicia","family":"Ito Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-6152","authenticated-orcid":false,"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"4393_CR1","doi-asserted-by":"publisher","unstructured":"Heidari, F., Afshari, M., & Moosazadeh, M. (2017). Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatology international, 37(9), 1527\u201339. https:\/\/doi.org\/10.1007\/s00296-017-3725-2","DOI":"10.1007\/s00296-017-3725-2"},{"key":"4393_CR2","doi-asserted-by":"publisher","unstructured":"Iannuccelli, C., Favretti, M., Dolcini, G., Di Carlo, M., Pellegrino, G., Bazzichi, L. (2025). Fibromyalgia: One year in review 2025. Clinical and Experimental Rheumatology, 43(6), 957\u201369. https:\/\/doi.org\/10.55563\/clinexprheumatol\/buhd2z","DOI":"10.55563\/clinexprheumatol\/buhd2z"},{"key":"4393_CR3","doi-asserted-by":"publisher","unstructured":"Soza\u0144ska, A., Soza\u0144ski, B., \u0141agowska-Sado, A., Wilmowska-Pietruszy\u0144ska, A., & Wisniowska-Szurlej, A. (2024). Disability assessment with WHODAS 2.0 of people with fibromyalgia in Poland: A cross sectional-study. Medical Science Monitor, 30, e945450. https:\/\/doi.org\/10.12659\/MSM.945450","DOI":"10.12659\/MSM.945450"},{"key":"4393_CR4","doi-asserted-by":"publisher","unstructured":"Clauw, D. J. (2014). Fibromyalgia: A clinical review. JAMA, 311(15), 1547\u201355. https:\/\/doi.org\/10.1001\/jama.2014.3266","DOI":"10.1001\/jama.2014.3266"},{"key":"4393_CR5","doi-asserted-by":"publisher","unstructured":"Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., H\u00e4user, W., Katz, R. L. (2016). 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism, 46(3), 319\u201329. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.012","DOI":"10.1016\/j.semarthrit.2016.08.012"},{"key":"#cr-split#-4393_CR6.1","unstructured":"Center for Drug Evaluation, Research, Food, U. S., & Administration, D. (2009). FDA"},{"key":"#cr-split#-4393_CR6.2","unstructured":"[cited 2026 Jul 16]. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims"},{"key":"4393_CR7","doi-asserted-by":"publisher","unstructured":"Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. P. (2005). Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, 113(1\u20132), 9\u201319. https:\/\/doi.org\/10.1016\/j.pain.2004.09.012","DOI":"10.1016\/j.pain.2004.09.012"},{"key":"4393_CR8","doi-asserted-by":"publisher","unstructured":"Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B. (2003). Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain, 106(3), 337\u201345. https:\/\/doi.org\/10.1016\/j.pain.2003.08.001","DOI":"10.1016\/j.pain.2003.08.001"},{"key":"4393_CR9","doi-asserted-by":"publisher","unstructured":"Jurado-Priego, L. N., Cueto-Ure\u00f1a, C., Ram\u00edrez-Exp\u00f3sito, M. J., Mart\u00ednez-Martos, J. M., & Fibromyalgia (2024). A review of the pathophysiological mechanisms and multidisciplinary treatment strategies. Biomedicines, 12(7), 1543. https:\/\/doi.org\/10.3390\/biomedicines12071543","DOI":"10.3390\/biomedicines12071543"},{"key":"4393_CR10","doi-asserted-by":"publisher","unstructured":"D\u00f6hmen, A., Kock, M., Fischer, F., Rose, M., Obbarius, A., & Klapproth, C. P. (2023). Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures. Quality of Life Research, 32(6), 1521\u201336. https:\/\/doi.org\/10.1007\/s11136-022-03261-5","DOI":"10.1007\/s11136-022-03261-5"},{"key":"4393_CR11","doi-asserted-by":"publisher","unstructured":"Williamson, P. R., Altman, D. G., Blazeby, J. M., Clarke, M., Devane, D., Gargon, E. (2012). Developing core outcome sets for clinical trials: Issues to consider. Trials, 13(1), 132. https:\/\/doi.org\/10.1186\/1745-6215-13-132","DOI":"10.1186\/1745-6215-13-132"},{"key":"4393_CR12","doi-asserted-by":"publisher","unstructured":"Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011). The ClinicalTrials.gov results database\u2014update and key issues. The New England Journal of Medicine, 364(9), 852\u201360. https:\/\/doi.org\/10.1056\/NEJMsa1012065","DOI":"10.1056\/NEJMsa1012065"},{"key":"4393_CR13","doi-asserted-by":"publisher","unstructured":"Viergever, R. F., Karam, G., Reis, A., & Ghersi, D. (2014). The quality of registration of clinical trials: Still a problem. PLoS One,9(1), e84727. https:\/\/doi.org\/10.1371\/journal.pone.0084727","DOI":"10.1371\/journal.pone.0084727"},{"key":"4393_CR14","unstructured":"OSF [cited 2026 Jul 17]. Available from: https:\/\/osf.io\/6wnms\/overview?view_only=7c44541ce90c4869801b7b60321c24c1"},{"key":"4393_CR15","unstructured":"fibromyalgia Github; [cited 2026 Jul 18]. Available from: https:\/\/github.com\/micaylonresearch-design\/fibromyalgia"},{"key":"4393_CR16","doi-asserted-by":"publisher","unstructured":"Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics,33(1), 159\u201374. https:\/\/doi.org\/10.2307\/2529310","DOI":"10.2307\/2529310"},{"key":"4393_CR17","unstructured":"[cited 2026 Jul 20] Available from: https:\/\/clinicaltrials.gov\/api\/v2\/studies"},{"key":"4393_CR18","doi-asserted-by":"publisher","unstructured":"Patel, K. V., Amtmann, D., Jensen, M. P., Smith, S. M., Veasley, C., & Turk, D. C. (2021). Clinical outcome assessment in clinical trials of chronic pain treatments. Pain Reports, 6(1), e784. https:\/\/doi.org\/10.1097\/PR9.0000000000000784","DOI":"10.1097\/PR9.0000000000000784"},{"key":"4393_CR19","doi-asserted-by":"publisher","unstructured":"Choy, E. H., Arnold, L. M., Clauw, D. J., Crofford, L. J., Glass, J. M., Simon, L. S. (2009). Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. The Journal of Rheumatology, 36(10), 2330\u20134. https:\/\/doi.org\/10.3899\/jrheum.090368","DOI":"10.3899\/jrheum.090368"},{"key":"4393_CR20","doi-asserted-by":"publisher","unstructured":"Mease, P., Arnold, L. M., Choy, E. H., Clauw, D. J., Crofford, L. J., Glass, J. M. (2009). Fibromyalgia syndrome module at OMERACT 9: Domain construct. The Journal of Rheumatology, 36(10), 2318\u201329. https:\/\/doi.org\/10.3899\/jrheum.090367","DOI":"10.3899\/jrheum.090367"},{"key":"4393_CR21","unstructured":"Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The fibromyalgia impact questionnaire: Development and validation. The Journal of Rheumatology, 18(5), 728\u201333. https:\/\/pubmed.ncbi.nlm.nih.gov\/1865419\/"},{"key":"4393_CR22","doi-asserted-by":"publisher","unstructured":"Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009). The revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. Arthritis Research & Therapy, 11(4), R120. https:\/\/doi.org\/10.1186\/ar2783","DOI":"10.1186\/ar2783"},{"key":"4393_CR23","unstructured":"Dunkl, P. R., Taylor, A. G., McConnell, G. G., Alfano, A. P., & Conaway, M. R. (2000). Responsiveness of fibromyalgia clinical trial outcome measures. The Journal of Rheumatology, 27(11), 2683\u201391."},{"key":"4393_CR24","doi-asserted-by":"publisher","unstructured":"Ferreira-Valente, M. A., Pais-Ribeiro, J. L., & Jensen, M. P. (2011). Validity of four pain intensity rating scales. Pain, 152(10), 2399\u2013404. https:\/\/doi.org\/10.1016\/j.pain.2011.07.005","DOI":"10.1016\/j.pain.2011.07.005"},{"key":"4393_CR25","unstructured":"Core Outcome Sets \u2013 OMERACT [cited 2026 Jul 20]. Available from: https:\/\/omeract.org\/cos\/"},{"key":"4393_CR26","doi-asserted-by":"publisher","unstructured":"Mazzei, L. G., Bergamaschi, C., de Silva, C., Barberato Filho, M. T., Fulone, S., Moura, I. (2020). Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: A methodological survey. PLoS One, 15(4), e0231444. https:\/\/doi.org\/10.1371\/journal.pone.0231444","DOI":"10.1371\/journal.pone.0231444"},{"key":"4393_CR27","doi-asserted-by":"publisher","unstructured":"Krsticevic, M., Dosenovic, S., Dimcea, D. A. M., Jedrzejewska, D., Marques Lameir\u00e3o, A. C., Almeida, E. S. (2020). Outcome domains, outcome measures, and characteristics of randomized controlled trials testing nonsurgical interventions for osteoarthritis. The Journal of Rheumatology, 47(1), 126\u201331. https:\/\/doi.org\/10.3899\/jrheum.180985","DOI":"10.3899\/jrheum.180985"},{"key":"4393_CR28","doi-asserted-by":"publisher","unstructured":"Chiarotto, A., Boers, M., Deyo, R. A., Buchbinder, R., Corbin, T. P., Costa, L. O. P. (2018). Core outcome measurement instruments for clinical trials in nonspecific low back pain. Pain, 159(3), 481\u201395. https:\/\/doi.org\/10.1097\/j.pain.0000000000001117","DOI":"10.1097\/j.pain.0000000000001117"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04393-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:32:11Z","timestamp":1793370731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04393-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4393"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04393-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-10425582\/v1","asserted-by":"object"}]},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MV reports receiving funding from the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the U.S. Office of Research Integrity, the Oklahoma Center for the Advancement of Science and Technology, the National Park Service, the National Endowment for the Arts, the U.S. Department of Education, the U.S. Department of State (through the U.S. Embassy in Tokyo), and Oklahoma State University Center for Health Sciences. All funding was received outside the submitted work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Oklahoma State University Center for Health Sciences Institutional Review Board determined this study to be exempt (IRB #2026032). The study used publicly available ClinicalTrials.gov registration data and involved no direct human participants or identifiable patient information.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"291"}}